Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
180 patients will be randomly divided into two groups 90 patients each using a
computer-generated program.
Group R: 90 patients will receive a Rivastigmine patch (4.6 mg) 24 h before the operation to
3 days post-operative Group M: 90 patients will receive Melatonin patch (7 mg) 24 h before
the operation to 3 days post-operative Patients in the two groups will be compared regarding
incidence and severity of delirium on postoperative days 1, 2 or 3 and 7